Free Trial

MaxLinear (MXL) Projected to Post Earnings on Thursday

MaxLinear logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Q1 2026 earnings due April 23 (after market close): Analysts expect MaxLinear to report EPS of $0.1873 and revenue of $137.15 million, with a conference call scheduled for 4:30 PM ET.
  • Recent results showed a beat (Q prior EPS $0.19 vs. $0.18 est.) and revenue up 48% year-over-year to $136.44 million, but the company still posts a negative net margin (29.23%) and negative ROE (6.95%).
  • Analyst consensus is a Hold with an average price target of $19.57 (Benchmark raised to $28, Wells Fargo to $20), while insiders sold shares recently and institutional ownership is high at about 90.8%.
  • Five stocks we like better than MaxLinear.

MaxLinear (NASDAQ:MXL - Get Free Report) is expected to be posting its Q1 2026 results after the market closes on Thursday, April 23rd. Analysts expect MaxLinear to post earnings of $0.1873 per share and revenue of $137.1480 million for the quarter. Individuals are encouraged to explore the company's upcoming Q1 2026 earning overview page for the latest details on the call scheduled for Thursday, April 23, 2026 at 4:30 PM ET.

MaxLinear (NASDAQ:MXL - Get Free Report) last issued its earnings results on Thursday, January 29th. The semiconductor company reported $0.19 earnings per share for the quarter, topping analysts' consensus estimates of $0.18 by $0.01. MaxLinear had a negative net margin of 29.23% and a negative return on equity of 6.95%. The firm had revenue of $136.44 million during the quarter, compared to analyst estimates of $134.82 million. During the same quarter last year, the business earned ($0.09) earnings per share. The company's quarterly revenue was up 48.0% on a year-over-year basis. On average, analysts expect MaxLinear to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

MaxLinear Price Performance

MXL stock opened at $22.01 on Thursday. The firm has a 50 day moving average of $18.06 and a 200-day moving average of $17.30. The company has a current ratio of 1.34, a quick ratio of 0.92 and a debt-to-equity ratio of 0.27. MaxLinear has a 12 month low of $9.07 and a 12 month high of $22.07. The firm has a market capitalization of $1.90 billion, a P/E ratio of -13.93 and a beta of 1.70.

Analysts Set New Price Targets

Several research analysts have commented on the stock. Wells Fargo & Company lifted their price target on shares of MaxLinear from $18.00 to $20.00 and gave the stock an "equal weight" rating in a research note on Friday, January 30th. Weiss Ratings reissued a "sell (d-)" rating on shares of MaxLinear in a research note on Thursday, January 22nd. Finally, Benchmark lifted their price target on shares of MaxLinear from $25.00 to $28.00 and gave the stock a "buy" rating in a research note on Friday, January 16th. Two equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $19.57.

Get Our Latest Stock Analysis on MXL

Insider Activity at MaxLinear

In other MaxLinear news, insider Steven G. Litchfield sold 20,000 shares of the business's stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $17.50, for a total transaction of $350,000.00. Following the transaction, the insider directly owned 368,364 shares of the company's stock, valued at approximately $6,446,370. The trade was a 5.15% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders have sold 44,929 shares of company stock valued at $746,456 over the last quarter. 7.70% of the stock is owned by insiders.

Institutional Trading of MaxLinear

Hedge funds and other institutional investors have recently modified their holdings of the business. The Manufacturers Life Insurance Company boosted its stake in MaxLinear by 27.8% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 2,889,111 shares of the semiconductor company's stock worth $41,054,000 after purchasing an additional 628,719 shares in the last quarter. Invesco Ltd. boosted its stake in MaxLinear by 419.9% in the 4th quarter. Invesco Ltd. now owns 2,149,589 shares of the semiconductor company's stock worth $37,467,000 after purchasing an additional 1,736,141 shares in the last quarter. Geode Capital Management LLC boosted its stake in MaxLinear by 1.4% in the 4th quarter. Geode Capital Management LLC now owns 2,038,144 shares of the semiconductor company's stock worth $35,531,000 after purchasing an additional 28,548 shares in the last quarter. Marshall Wace LLP boosted its stake in MaxLinear by 31.8% in the 3rd quarter. Marshall Wace LLP now owns 1,826,259 shares of the semiconductor company's stock worth $29,366,000 after purchasing an additional 441,088 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in MaxLinear by 0.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,576,634 shares of the semiconductor company's stock worth $27,482,000 after purchasing an additional 6,052 shares in the last quarter. 90.79% of the stock is owned by hedge funds and other institutional investors.

MaxLinear Company Profile

(Get Free Report)

MaxLinear, Inc is a provider of radio-frequency (RF), analog, and mixed-signal integrated circuits for broadband communications, data center connectivity, and video infrastructure applications. The company's product portfolio includes high-performance RF front-end modules, broadband power amplifiers, optical and Ethernet transceivers, and network processors designed to support demanding signal processing requirements.

MaxLinear's semiconductor solutions are used by cable and satellite television operators, fiber-to-the-home service providers, network equipment manufacturers, and data center operators.

Read More

Earnings History for MaxLinear (NASDAQ:MXL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in MaxLinear Right Now?

Before you consider MaxLinear, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MaxLinear wasn't on the list.

While MaxLinear currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before SpaceX Goes Public Cover

A forward-looking investment report spotlighting the seven space companies best positioned to benefit from accelerating commercialization in 2026. It explores key industry trends, major growth catalysts, and the stocks shaping the next phase of the space economy—from launch leaders and satellite networks to data, defense, and in-space infrastructure.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines